Menu
MapConnectionsTopicsBulgariaThe Night (K-TRIO)Marie Skłodowska-CurieFor studentsFor teachersMethodologySurprise me
HEDoctoral network2022–2026

NANOREMEDI · Functional Nano-Scaffolds for Regenerative Medicine

Horizon Europe — Marie Skłodowska-Curie Actions

Duration
2022-09-01 → 2026-11-30
EU contribution
€3,413,326
Participants
19
Scheme
HORIZON-TMA-MSCA-DN-JD

Lines connect the coordinator with its partners.

Results in brief

Functional Nano-Scaffolds for Regenerative Medicine

The Horizon Europe MSCA-Doctoral Network NanoReMedi “Functional Nano-Scaffolds for Regenerative Medicine” is run by an international consortium of universities in cooperation with the private sector. It provides innovative PhD level training on nanomaterials through a highly multidisciplinary approach involving several of state-of-the-art technologies and methodologies (computational and synthetic chemistry, nanomaterial production and characterization). The research focus is on nanomaterials for regenerative medicine, a strong potential area for training a new generation of doctoral candidates (DCs) as future professionals crucial in the European nanotechnology field. To provide world-class training to 13 DCs, three case studies in regenerative medicine were selected: 1. Tissue engineered vascular grafts to replace damaged peripheral arteries. 2. Stem-cell based regenerative medicine for bone and cartilage repair 3. Facing with implantation failure of engineered tissues/scaffolds. Nanoremedi website https://www.nanoremedi.eu/

Data: CORDIS, © European Union

Project objective

Repair or replacement of tissue and organ functions lost due to age, disease or damage represents one of the most urgent medical needs of our aging society. The NanoReMedi Consortium will contribute to addressing this fundamentally important issue by using a new and efficient scientific approach relying on the design, preparation, characterization and validation of conceptually innovative peptide-based functional nanomaterials for regenerative medicine applications. Specifically, NanoReMedi will tackle three highly relevant case studies: “Tissue engineered vascular grafts to replace damaged peripheral arteries”, “Stem-cell based regenerative medicine for bone and cartilage repair” and “Facing with implantation failure” this last addressed to overcome bacterial severe infections. As an equally important goal, the NanoReMedi Consortium aims to build a world-class doctoral educational model in the field of nanomaterials applied to regenerative nanomedicine, through a strategically designed Academia-Industry interplay. To this end, 6 Beneficiaries, one Associated Partner linked to a beneficiary and 12 non-academic associated partners will join their forces to: i)create a highly innovative research network for training a new generation of 13 Doctoral Candidates (DCs) with strong employment potential, aimed at studying and developing “Functional Nano-Scaffolds for Regenerative Medicine”; ii)establish a robust structure for long-term research cooperation between a pool of leading Universities and Enterprises, for broadening and strengthening the knowledge and skills of DCs accessing the nanoscience-area from adjacent disciplines (such as chemistry, material sciences and bioinformatics); iii)building a solid foundation for long-term European excellence in medical nanotechnology via dissemination of research/training outcomes - through cross-network secondments, Summer Schools workshops and transferable skills modules, and of the best practice generated by NanoReMedi.

Original text from CORDIS.

Participants

  • UNIVERSITA DEGLI STUDI DI MILANO · MilanoCoordinatorItaly
  • AB MEDICA SPA · MilanoItaly
  • ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN NANOCIENCIAS CIC NANOGUNE · San SebastianSpain
  • Bayer HealthCare Manufacturing S.r.l. · MilanoItaly
  • Bio Basic Europe S.r.l. · MilanoItaly
  • DELOITTE ADVISORY S.R.L. SOCIETA BENEFIT · MILANOItaly
  • De Lama spa · San Martino SiccomarioItaly
  • EDELWEISS CONNECT GMBH · BaselSwitzerland
  • GENEPEP SA · SAINT JEAN DE VEDASFrance
  • ITALFARMACO S.p.A. · MilanoItaly
  • Jacobacci & Partners S.p.A. · TorinoItaly
  • LYNXTER · BayonneFrance
  • Ponti & Partners, SLP · BarcelonaSpain
  • SIMUNE ATOMISTICS SL · Donostia San SebastianSpain
  • THE HEBREW UNIVERSITY OF JERUSALEM · JerusalemIsrael
  • UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA · LeioaSpain
  • UNIVERSITA DEGLI STUDI DI PAVIA · PaviaItaly
  • UNIVERSITAT POLITECNICA DE CATALUNYA · BARCELONASpain
  • UNIVERSITE DE MONTPELLIER · MontpellierFrance

Links

Data: CORDIS, © European Union